OperA
AI in colonoscopy – a smart way to improve the diagnosis and therapy of colorectal cancer.
News
-
ACCEPT inclusion numbers Dec. 13, 2023
The number of included screening patients in the OperA WP 1, the ACCEPT trial, is increasing steadily each month.
-
Continuous exposure to AI might reduce the skills of the endoscopist Aug. 13, 2025
The ACCEPT team, part of the UiO OperA EU project, published a paper this week in the Lancet Gastroenterology and Hepatology that may generate controversy in the field of AI and colonoscopy.
-
AI-assisted colonoscopy could reduce overtreatment and costs Feb. 27, 2025
PhD fellow Natalie Halvorsen published a paper on AI-assisted colonoscopy in this week's Endoscopy journal. The paper investigates the cost-effectiveness of leaving harmless polyps in the colon when adding AI as a decision-making tool.
-
New data on the importance of sigmoidoscopy screening in The Lancet Gastroenterology and Hepatology Aug. 6, 2024
In The Lancet Gastroenterology & Hepatology, Kate Wooldrage and colleagues present an update about the long-term effects of sigmoidoscopy on colorectal cancer incidence and mortality. Professor Michael Bretthauer and assoc. prof. Nastazja Pilonis dive deeper into the matter in a linked editorial.